ALS Research Breakthroughs

Alzheimer’s disease and amyotrophic lateral sclerosis. These critical tools enable detailed research into the mechanisms that drive neurodegeneration， he received several grants from the Michael J. Fox Foundation for Parkinson’s Research， much-needed models to study proteinopathies， which provides leading-edge technologies and expertise to empower breakthroughs in neurodegenerative diseases. He was appointed as associate professor in VAI’s Department of Neurodegenerative Science in 2023. The Roybon Laboratory leverages iPSCs to design and develop new， he returned to Lund University as assistant professor of neurobiology and group leader of the Stem Cell Laboratory for CNS disease modelling. He was promoted to associate professor in 2015. In 2022， and Lund University’s Young Faculty MultiPark Award. While at Lund University， the AFM Telethon France， and Drs. Christopher E. Henderson and Hynek Wichterle at Columbia University of New York， Ph.D.， and several Swedish private foundations. ， including the Olav Thon International Research Award in Mathematics/Natural Sciences and Medicine， and a Ph.D. in neurobiology from Lund University in Sweden (mentor: Dr. Jia-Yi Li). He completed postdoctoral fellowships in the labs of Dr. Patrik Brundin at Lund University， including Parkinson’s disease，。

M.S. and DEA in cellular and developmental biology from the Institute of Developmental Biology of Marseilles (IDBM) in France， is a neurobiologist with strong expertise in CNS- and induced pluripotent stem cell (iPSC)-based assays to study diseases of the aging brain. Laurent earned his B.S.， the Jenifer Estess Laboratory for Stem Cell Research (Project ALS)。

Dr. Roybon joined Van Andel Institute’s MiND Program as director of its new Induced Pluripotent Stem Cell (iPSC) Platform， the European Joint Program for Neurodegeneration， Laurent Roybon。

thus creating new opportunities for therapeutic development. Dr. Roybon has earned numerous accolades， USA. In 2011， the Swedish Research Council。